Citation Impact
Citing Papers
In vivo Optical Molecular Imaging of Vascular Endothelial Growth Factor for Monitoring Cancer Treatment
2008
Silencing of Epidermal Growth Factor Receptor Suppresses Hypoxia-Inducible Factor-2–Driven VHL −/− Renal Cancer
2005
EglN2 associates with the NRF 1‐ PGC 1α complex and controls mitochondrial function in breast cancer
2015 StandoutNobel
Ligand-tethered lipid nanoparticles for targeted RNA delivery to treat liver fibrosis
2023 StandoutNobel
An Integrated Approach for Analysis of the DNA Damage Response in Mammalian Cells
2015 StandoutNobel
Altered metabolite levels in cancer: implications for tumour biology and cancer therapy
2016
Bioorthogonal Chemistry: Fishing for Selectivity in a Sea of Functionality
2009 StandoutNobel
Evaluation of indenoisoquinoline topoisomerase I inhibitors using a hollow fiber assay
2006
Clinical studies of reversal of drug resistance based on glutathione
1998
Cisplatin: From DNA damage to cancer chemotherapy
2001
DNA-based asymmetric catalysis
2010 StandoutNobel
Synthesis and biological study of a flavone acetic acid analogue containing an azido reporting group designed as a multifunctional binding site probe
2005
Inhibition of in vitro VEGF expression and choroidal neovascularization by synthetic dendrimer peptide mediated delivery of a sense oligonucleotide
2004
l-S,R-buthionine sulfoximine: historical development and clinical issues
1998
Molecular mechanisms of drug resistance
2005
Niosomes and Polymeric Chitosan Based Vesicles Bearing Transferrin and Glucose Ligands for Drug Targeting
2000
Prodrug Strategies in Anticancer Chemotherapy
2007
Pharmacology of imatinib (STI571)
2002
Cellular Senescence in Cancer and Aging
2007 Standout
Telomere states and cell fates
2000 StandoutNatureNobel
Severe cachexia in mice inoculated with interferon‐γ‐producing tumor cells
1991
DNA-based therapeutics and DNA delivery systems: A comprehensive review
2005
G‐Quadruplexes: Targets in Anticancer Drug Design
2008
Synthesis and Binding Studies of Novel Diethynyl‐Pyridine Amides with Genomic Promoter DNA G‐Quadruplexes
2011
Natural and pharmacological regulation of telomerase
2002
Overcoming the immortality of tumour cells by telomere and telomerase based cancer therapeutics – current status and future prospects
2005
DNA Modifications by antitumor platinum and ruthenium compounds: Their recognition and repair
2002
Exploiting tumour hypoxia in cancer treatment
2004 Standout
The experimental development of bioreductive drugs and their role in cancer therapy
1993
Drug delivery of oligonucleotides by peptides
2004
Polymer Therapeutics: Concepts and Applications
2006
Chemical remodelling of cell surfaces in living animals
2004 StandoutNatureNobel
The role of helper lipids in lipid nanoparticles (LNPs) designed for oligonucleotide delivery
2016
Low-molecular-weight polyethylenimine as a non-viral vector for DNA delivery: comparison of physicochemical properties, transfection efficiency and in vivo distribution with high-molecular-weight polyethylenimine
2003
Stimuli-responsive polymeric nanocarriers for the controlled transport of active compounds: Concepts and applications
2012
Targeting gene expression to hypoxic tumor cells
1997 StandoutNobel
Switching and Signaling at the Telomere
2001 StandoutNobel
Nucleolar protein PinX1p regulates telomerase by sequestering its protein catalytic subunit in an inactive complex lacking telomerase RNA
2004 StandoutNobel
The application of DNA and RNA G-quadruplexes to therapeutic medicines
2011
Glutathione deficiency produced by inhibition of its synthesis, and its reversal; Applications in research and therapy
1991
Rapid upregulation of telomerase activity in human leukemia HL-60 cells treated with clinical doses of the DNA-damaging drug etoposide
2002
Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease
1992 StandoutNature
Tumor-activated Prodrugs—A New Approach to Cancer Therapy
2004
N-fused porphyrin with pyridinium side-arms: a new class of aromatic ligand with DNA-binding ability
2011
New platinum antitumor complexes
1993
Evaluation of Generation 2 and 3 Poly(Propylenimine) Dendrimers for the Potential Cellular Delivery of Antisense Oligonucleotides Targeting the Epidermal Growth Factor Receptor
2004
Human Endothelial Cell Life Extension by Telomerase Expression
1999
The Exclusivity of Multivalency in Dynamic Covalent Processes
2004 StandoutNobel
Maltodextrin-based proniosomes
2001
Click Chemistry for Drug Development and Diverse Chemical–Biology Applications
2013 Standout
Fluorine in medicinal chemistry
2007 Standout
Solid-Phase Synthesis of Multivalent Glycoconjugates on a DNA Synthesizer
2002
Methylglyoxal Synthetase, Enol-Pyruvaldehyde, Glutathione and the Glyoxalase System
2002 StandoutNobel
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Biochemical Modulation of Cisplatin Mechanisms of Action: Enhancement of Antitumor Activity and Circumvention of Drug Resistance
2003 Standout
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Supramolecular Coordination: Self-Assembly of Finite Two- and Three-Dimensional Ensembles
2011 Standout
Emerging DNA topoisomerase inhibitors as anticancer drugs
2004
A contractile and counterbalancing adhesion system controls the 3D shape of crawling cells
2014 StandoutNobel
Highly Efficient G-Quadruplex Recognition by Bisquinolinium Compounds
2007
A Platinum Supramolecular Square as an Effective G-Quadruplex Binder and Telomerase Inhibitor
2008
DNA Topoisomerase I Inhibitors: Chemistry, Biology, and Interfacial Inhibition
2009 Standout
One-Component Multifunctional Sequence-Defined Ionizable Amphiphilic Janus Dendrimer Delivery Systems for mRNA
2021 StandoutNobel
G‐Quadruplex DNA Structures and Organic Chemistry: More Than One Connection
2009
Current Status of Platinum-Based Antitumor Drugs
1999 Standout
Nonviral Vectors for Gene Delivery
2008 Standout
Structural Basis of Telomeric RNA Quadruplex−Acridine Ligand Recognition
2011
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
Asymmetric Catalysis by Architectural and Functional Molecular Engineering: Practical Chemo- and Stereoselective Hydrogenation of Ketones
2001 StandoutNobel
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Kinase requirements in human cells: III. Altered kinase requirements inVHL−/− cancer cells detected in a pilot synthetic lethal screen
2008 StandoutNobel
Gold Nanoparticles in Chemical and Biological Sensing
2012 Standout
Modulation of the Catalytic Behavior of α-Chymotrypsin at Monolayer-Protected Nanoparticle Surfaces
2006
Artificial Molecular Machines
2015 Standout
Structure, Recognition, and Processing of Cisplatin−DNA Adducts
1999 Standout
Enzyme-Responsive Snap-Top Covered Silica Nanocontainers
2008 StandoutNobel
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Hypoxia-inducible factor 1-dependent expression of platelet-derived growth factor B promotes lymphatic metastasis of hypoxic breast cancer cells
2012 StandoutNobel
Activatable Photosensitizers for Imaging and Therapy
2010 Standout
Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding
2009 StandoutScience
Fluorescent Chemosensors Based on Spiroring-Opening of Xanthenes and Related Derivatives
2011 Standout
Mechanism-Based Competitive Inhibitors of Glyoxalase I: Intracellular Delivery, in Vitro Antitumor Activities, and Stabilities in Human Serum and Mouse Serum
1999
Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization
2010 Standout
Impact of Natural Products on Developing New Anti-Cancer Agents
2009 Standout
Polypropylenimine dendrimer-induced gene expression changes: The effect of complexation with DNA, dendrimer generation and cell type
2005
A low threshold level of expression of mutant-template telomerase RNA inhibits human tumor cell proliferation
2001 StandoutNobel
Advances in Wound-Healing Assays for Probing Collective Cell Migration
2012
Oligonucleotide-Modified Gold Nanoparticles for Intracellular Gene Regulation
2006 StandoutScience
Dendrimers Designed for Functions: From Physical, Photophysical, and Supramolecular Properties to Applications in Sensing, Catalysis, Molecular Electronics, Photonics, and Nanomedicine
2010 Standout
Heterocyclic Nanographenes and Other Polycyclic Heteroaromatic Compounds: Synthetic Routes, Properties, and Applications
2016 Standout
Photopharmacology: Beyond Proof of Principle
2014 StandoutNobel
Dendritic vectors for gene transfection
2006
Metal–Organic Frameworks and Self-Assembled Supramolecular Coordination Complexes: Comparing and Contrasting the Design, Synthesis, and Functionality of Metal–Organic Materials
2012 Standout
Chitosan Chemistry and Pharmaceutical Perspectives
2004 Standout
Multiple Binding Modes of Inhibitors to Carbonic Anhydrases: How to Design Specific Drugs Targeting 15 Different Isoforms?
2012 Standout
Works of John A. Double being referenced
Antitumour activity of S-p-bromobenzylglutathione cyclopentyl diester in vitro and in vivo
1996
True
2000
DT-diaphorase activity correlates with sensitivity to the indoloquinone EO9 in mouse and human colon carcinomas
1992
Distribution, Metabolism and Tumoricidal Activity of Doxorubicin Administered in Sorbitan Monostearate (Span 60) Niosomes in the Mouse
1995
A Critical Appraisal of the Predictive Value of In Vitro Chemosensitivity Assays
1990
EO9: A novel bioreductive alkylating indoloquinone with preferential solid tumour activity and lack of bone marrow toxicity in preclinical models
1993
Quantitative Angiogenesis Assays in vivo – A Review
2004
Synthesis and Antitumour Activity of New Derivatives of Flavone‐8‐acetic Acid (FAA). Part 2: Ring‐Substituted Derivatives
1997
The delivery of antisense therapeutics
2000
Therapeutic Index: A Vital Component in Selection of Anticancer Agents for Clinical Trial
1989
Inhibition of telomerase activity by cisplatin in human testicular cancer cells
1997
Comparison of nitrogen‐mustard‐sensitive and ‐resistant yoshida sarcomas
1966
The G-Quadruplex-Interactive Molecule BRACO-19 Inhibits Tumor Growth, Consistent with Telomere Targeting and Interference with Telomerase Function
2005
The role of p53 in the chemotherapeutic responses to cisplatin, doxorubicin and 5-fluorouracil treatment
2004
Characterization of a transplantable adenocarcinoma of the mouse colon producing cachexia in recipient animals.
1987
ChemInform Abstract: Synthesis and Antitumor Activity of New Derivatives of Flavone‐8‐ acetic Acid (FAA). Part 2. Ring‐Substituted Derivatives
1997
Pharmacokinetics of PK1 and doxorubicin in experimental colon tumor models with differing responses to PK1.
1999